RO7122290
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7122290, covering 2025-07-14 to 2025-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment [Phase 1]